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Abstract: The process of laser-mediated ablation of cancer cells marked with biofunctionalized 
carbon nanotubes is frequently called “nanophotothermolysis”. We herein present a method of 
selective nanophotothermolisys of pancreatic cancer (PC) using multiwalled carbon nanotubes 
(MWCNTs) functionalized with human serum albumin (HSA). With the purpose of testing 
the therapeutic value of these nanobioconjugates, we have developed an ex-vivo experimental 
platform. Surgically resected specimens from patients with PC were preserved in a cold medium 
and kept alive via intra-arterial perfusion. Additionally, the HSA-MWCNTs have been intra-
arterially administered in the greater pancreatic artery under ultrasound guidance. Confocal and 
transmission electron microscopy combined with immunohistochemical staining have confirmed 
the selective accumulation of HSA-MWCNTs inside the human PC tissue. The external laser 
irradiation of the specimen has significantly produced extensive necrosis of the malign   tissue 
after the intra-arterial administration of HSA-MWCNTs, without any harmful effects on 
the   surrounding healthy parenchyma. We have obtained a selective photothermal ablation of the 
malign tissue based on the selective internalization of MWCNTs with HSA cargo inside the 
pancreatic adenocarcinoma after the ex-vivo intra-arterial perfusion.
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Introduction
Pancreatic cancer (PC) is the fourth leading cause of cancer death in the United States, 
with an overall 5-year survival rate of less than 5%.1 Only the surgical resection of the 
primary tumor provides clinical benefit and improvement in survival. However, this 
is rarely achieved in practice because, at the time of diagnosis, most PC patients have 
advanced-stage disease and experience various symptoms such as severe pain, jaundice, 
and weight loss. PC is also one of the most intrinsically drug-resistant of all tumors and 
the lack of effective cytostatics contributes to the increased mortality rates.2
The development of targeted therapy represents an exciting and new approach to 
PC treatment. Conceptually speaking, a targeted drug represents a responsive molecule 
attached to a delivery carrier with affinity for specific surface receptor proteins located 
in cell membranes.3 Being endowed with target specificity, the carrier has the ability 
to concentrate only on the desired biological area. The use of these biological carriers 
for the development of specific and sensitive site-targeted bionanosystems makes the 
selective internalization of molecules with photothermal properties in cancer cells 
possible. This internalization process is not possible under normal conditions.4
Studies suggest that nanotechnologies could play a major role in the development 
of new anticancer therapies.5 Thermal approach of nanoparticles, nanoemulsion, International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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pH-responsive nanoparticles, nanoparticles used in 
  combination with radiation and nanovectors for drug delivery 
are the most explored nanoparticle-based cancer treatment 
methods.6
Nanotechnology has already brought to light promising 
results in PC research and treatment. Gold nanoparticles 
were used to achieve a radiofrequency-mediated necrosis 
of PC cells.7 F19 monoclonal antibodies conjugated to gold 
nanoparticles have demonstrated efficiency in targeting the 
pancreatic carcinoma tissue.8 Our previous work shows 
that carbon nanotubes (CNTs) alter the in-vitro molecular 
mechanisms of chemoresistance of PC cells.9
Highly proliferative tumor cells were shown to present 
intracytoplasmic albumin deposits.10 Another study confirmed 
that malign tumors are able to internalize albumin through 
endocytosis which is further processed in lysosomes.11 The 
resulting amino acids are further used for the synthesis of 
various substrates needed for tumor growth.12,13 Based on 
these properties, the anticancer effect of albumin has been 
intensively studied. For instance, a combination of cytostatic 
drug and albumin called Trexall™ is currently prescribed for 
the treatment of metastatic PC in humans.14
The research mechanisms involving the selective tumor 
targeting of biofunctionalized CNTs are currently being 
intensely explored due to the impressive ability of CNTs to 
convert near-infrared (NIR) laser radiation into heat. This 
intrinsic property provides an opportunity to develop a new 
generation of immunoconjugates for cancer   photo-therapy with 
high performance and efficacy in the selective   thermal abla-
tion of malignant cells.15 Although the idea and the principles 
of such bioconjugation hold a tremendous potential for the 
future, 100% selective internalization of nanobioconjugates 
in the cancer cells still remains problematic.16 While prog-
ress has been made regarding biofunctionalization of CNTs 
using various biological molecules such as DNA, antibodies, 
folates, and growth factors,17–19 there is a significant lack of 
knowledge on how to obtain selectivity of these compounds 
for a single type of cancer cell. This is due to the simultaneous 
presence of the receptors used for the specific binding of the 
targeting molecules to the membranes of the noncancerous 
cells too, although in smaller amount compared with the 
cancer cells.20
Animal models of human cancer have been widely 
used for testing experimental cancer nanotherapies.21 
Despite their popularity, these models exhibit major flaws 
because human tumor cells undergo kinetic changes after 
transplantation, and passage in the nude mice and the 
majority of the xenografted human tumors do not maintain 
the morphological and   biochemical characteristics of the 
  original tumors.22 Therefore, this methodological gap between 
  testing new cancer therapies in humans, on the one hand, 
and animal models, on the other hand, can be avoided using 
ex-vivo perfusion techniques of surgically resected organs 
under cold storage.23
Considering these data and the important role of albumin 
in tumor metabolism, we have used human albumin bound 
to multiwalled CNTs (MWCNTs) for the selective targeting 
of PC cells. Since ethical limitations made the selectivity 
and therapeutic potential of these nanocompounds in 
patients impossible to test, we have designed an original 
model of living PC. We used ex-vivo-perfused pancreatic 
  specimens that have been surgically removed from patients 
with ductal adenocarcinoma. On this model, the intra-arterial 
administration of albumin conjugated with MWCNTs 
specifically induced the release of this nanobioconjugate 
inside the malign tissue via the “capillary bed”. We present 
herein data suggesting that extensive and selective tumoral 
necrosis was obtained when the living pancreas underwent 
laser irradiation after the administration of human serum 
  albumin (HSA)-MWCNTs via the greater pancreatic artery.
Materials and methods
Antibodies and reagents
For the experiments involving the noncovalent function-
alization of CNTs, MWCNTs (.98% carbon basis, 
optical density [OD] × internal diameter [ID] × L 
10–15 nm × 2–6 nm × 0.1–10.0 ìm; product number: 
677248), HSA, and Sephacryl™ 100-HR were purchased 
from Sigma Chemical Co (Deisenhofen, Germany), and all 
the other chemicals were purchased from Merck (Darmstadt, 
Germany). For the experiments involving the biofunction-
alization of CNTs, pancreatic prelevation, and preservation 
we used Custodiol and Ringer solutions purchased from 
Essential Pharmaceutics (Newtown, PA). For experiments 
involving tissue viability, transferase dUTP nick end labeling 
(TUNEL) TMR Red assay was purchased from Roche Applied 
Science (Indianapolis, IN). For immunohistochemical stain-
ing, DRAQ5™ and 4′,6-diamidino-2-phenylindole (DAPI) 
were purchased from Sigma Chemical Co. Polyclonal gp60 
antibody (Ab) was prepared as previously described,24 and the 
fluorescent probe of cy3 derivative of anti-gp60 was prepared 
according to the existing protocol.25
cell culture
PANC-1 cells (ATCC CRL 1649) were maintained in RPMI 
(Roswell Park Memorial Institute) medium containing International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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10% fetal bovine serum (FBS), at 37°C, in a humidified 
atmosphere. For the experiments, cells were cultivated to 
confluence on 60 mm plates (BD Biosciences, Erembodegem, 
Belgium).
characterization of the cells
For the microscopy analysis, PANC-1 cells were trypsinized 
and transferred to 35 mm plates at a density of 25 × 104 
cells/dish. The cells were monitored by light microscopy 
(Olympus CKX 31, Munich, Germany).
Noncovalent functionalization  
of cNTs with hsA
MWCNTs (60 mg) were dispersed in a 3:1 (v/v) concentrated 
sulfuric and nitric acid mixture, and sonicated three times 
for 10 seconds each with a tip sonicator. Subsequently, the 
mixture was refluxed at 1200°C for 30 minutes. The oxidized 
MWCNTs treated in water solution were then centrifuged at 
8000 rpm, to remove any large unreacted CNTs and metallic 
impurities from the solution. Finally, the oxidized MWCNTs 
were vacuum filtered through a 0.2 µm polycarbonate filter 
(Whatman), until the elution was clear and had a neutral pH. 
The filter cake was dried overnight at room temperature. After 
filtration, the solution concentration was re-estimated using 
ultraviolet-visible near-infrared (UV-Vis-NIR) spectroscopy 
(Jasco-V 530, Gross-Umstadt, Germany). One milligram of 
fluorescein isothiocyanate (FITC) (10 mg/mL in dimethyl 
sulfoxide) was mixed with 50 mg HSA in sodium buffer 
(20 mM, pH 8.5), followed by incubation for 2 hours in 
darkness, at room temperature, with continuous stirring. The 
HSA-FITC conjugate was purified by gel chromatography, 
using a Sephacryl 100-HR column eluted with 10 mM 
phosphate buffered saline (PBS).30
Oxidized MWCNTs and HSA-FITC were mixed with 
deionized water at a concentration of 0.25 mg mL−1 and 
1.25 mg mL−1, respectively. The mixture was sonicated for 
1 hour with a tip sonicator under cooling in an ice bath, and 
then it was centrifuged for 5 minutes at 12000 rpm. The solids 
settled at the bottom of the centrifuge tube and consisted 
of unbound nanotubes, impurities, metals, and bundles of 
oxidized nanotubes. The resulting supernatant was collected 
and subjected to a second round of centrifugation. The 
collected supernatant contained the desired HSA-MWCNT 
conjugate.
Further, for a higher purification, the supernatant 
underwent gel chromatography for the purification 
  process. Sephacryl 100-HR that was presoaked and deaer-
ated using a vacuum pump was packed up to 15 cm in a 
2.5 cm diameter × 24 cm long glass column. The oxidized 
HSA-MWCNT supernatant recovered after centrifugation 
was layered on top of the gel and eluted using gravity water 
flow. Volume fractions were collected for 1-minute periods 
and analyzed for the presence of MWCNTs and HSA by 
measuring the absorbance at 500 and 280 nm, respectively, 
using the spectrophotometer (Jasco V530, Gross-Umstadt, 
Germany). Fractions with protein content were pooled for 
further use.26
Immunochemical experiments
For experiments describing the selective internalization of 
HSA-MWCNT conjugates in PC cells via GP60 receptors 
(Figure 1), we have used freshly plated PANC-1 cells 
adhering to glass coverslips. By means of temperature-
sensitive activation, PANC-1 cells have been exposed 
to cold (4°C) incubation for 60 minutes, in 5 mg HBSS 
(Hanks’ balanced salt solution), mixed with cy3-labeled 
anti-gp60 Ab. Unlabeled anti-gp60 Ab were included in the 
incubation mixture at a 10-fold molar excess (5 µg/mL) to 
prevent nonspecific adsorption of the fluorescent probe. The 
cells were washed twice with MWCNTs functionalized with 
HSA–FITC (50 mg/L) at 4°C. Then, the cells were rewarmed 
to 37°C for 15 minutes, allowing the occurrence of antibody 
internalization. In order to remove the antibody adhering to 
the cell surface, the cells were further washed three times at 
1-minute intervals with cold (4°C) acetate buffer (100 mM 
NaCl, 50 mM sodium acetate, pH 5.0). The cells immediately 
returned to 50 mg/L FITC-HSA-MWCNTs (pH 7.4). The 
coverslips were then transferred to the stage of a fluorescent 
microscope and examined for Cy3-labeled internalization.
Fluorescent staining procedures were performed in 
accordance with the manufacturer’s protocol for each dye. 
Fluorescent images were acquired using a Zeiss LSM 710 
confocal laser scanning unit equipped with argon and a HeNe 
laser mounted on a Axio Observer Z1 inverted microscope 
using 364, 488, and 568 nm excitation laser lines to detect 
DRAQ5 (BP590–650 nm emission), DAPI (BP385–470 nm 
ABC
Figure 1 selective targeting of gP60 receptors in pancreatic cancer cells. A, B) 
PANc-1 cell monolayers were coincubated (15 minutes at 37°c) with FITc-labeled 
hsA-MWcNTs (15 mg/L) A) plus indocyanine (cy3)-labeled anti-gp60 antibody B). 
C) co-localization of the cy3-gp60 antibody and FITc-hsA-MWcNTs. scale bar: 
5 µm. results are representative of three experiments. 
Abbreviations:  FITC,  fluorescein  isothiocyanate;  HSA,  human  serum  albumin; 
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emission), fluorescein isothiocyanate (FITC) (BP505–550 
emission), and Cy3 fluorescence (LP585 emission), 
respectively.
Pc harvesting
Six patients diagnosed with adenocarcinoma of the body 
of pancreas were referred to the 3rd Surgery Clinic, 
  Cluj-Napoca, Romania, for surgical treatment. In view of 
a localized pancreatic neoplasm, surgical removal of the 
tumor was planned for each patient. Each pancreatic tumor 
was found by palpation on the left side of the portal vein 
during laparotomy. This was confirmed by intraoperative 
ultrasonography, which showed hypoechogenic, well defined 
tumors, located between the isthmus and the corpus of the 
pancreas. The other parts of the pancreas appeared to be 
normal. Left splenopancreatectomy (distal pancreatectomy 
and splenectomy) with splenic, celiac, and hepatic lymph-
adenectomy was performed after the intraoperative identifica-
tion and preparation of the splenic artery and vein.
Pancreas preservation
Each specimen (the body and tail of the pancreas and the 
spleen) was transported in a sterile bag containing Custodiol 
solution, sealed with an adhesive strip, and placed in a second 
container which was also filled with Custodiol perfusion 
solution in order to avoid any failure of cooling by trapped 
air. Each specimen was safety ensured by the double packing, 
placed in a sterile plastic container, and the lid securely 
closed. The plastic container was further placed in a cooling 
box containing ice for the transportation from the surgery 
room to the laboratory.
Further, each specimen was immersed in a water bath for 
accurate temperature control at 5.5°C, filled with lactated 
Ringer’s solution (a crystalloid solution with a composition 
physiologically closer to that of plasma than 0.9% saline).
Custodiol solution, used for perfusion and flushing of 
donor pancreas in transplantology, was perfused through an 
appropriately prepared air-free perfusion tube system into the 
splenic artery located in the upper edge of the pancreas (at a 
flow rate of 1.5 mL per minute and per gram – the estimated 
weight of the specimen was between 80 and 110 g).
Separately, 50 mL of HSA-MWCNT solution (200 mg/L) 
diluted with 50 mL Custodiol was administered by gravity 
perfusion (the container was placed 1 m above the level of the 
bath, the perfusion rate flow was of 0.5 mL/s) in the greater 
pancreatic artery (a blood vessel that arises from splenic 
artery), under Doppler ultrasound guidance (Figure 2), to 
safely allow the flushing of the pancreatic “capillary bed” 
with HSA-MWCNT solution.
The length of the ex-vivo experiment was of about 
5 hours for each specimen, much less than the maximum 
time recommended (12–15 hours) for the preservation of the 
living pancreas during transplantation.27
Laser irradiation
A diode laser was fixed above the organ bath in a permanent 
position while the living pancreas was being kept immersed 
and perfused, as shown in Figure 2B. For the laser positioning 
above the malign lesion, ex-vivo ultrasound was performed 
on the surgical specimen. Thus, the laser diode was vertically 
placed 1 cm above the edge of the pancreas (1–3 cm above 
the hypoechogenic image inside the pancreatic parenchyma, 
depending on the morphological particularity of each laser-
treated specimen). We irradiated the pancreatic parenchyma 
containing the tumor mass for 30 minutes, using a 5 W/cm2, 
808 nm continuous laser generator (Apel Laser, Bucharest), in 
combination with the continuous intra-arterial administration 
of HSA-MWCNT-Custodiol solution.
Measurement of heat shock protein 
(hsP) expression
Specimens from various areas (both tumor and healthy tissue) 
were harvested after combined intra-arterial administration 
and external laser irradiation, and embedded in OCT 
cryomatrix (Sakura Finetek). Fluorescence immunostaining 
was performed on several sections for the measurement of 
HSP27 (green fluorescence) and HSP90 (red fluorescence) 
expression.
AB
Figure  2  A)  schematic  illustration  of  the  ex-vivo  thermal  ablation  of  human 
pancreatic adenocarcinoma on surgically resected specimens from the body and 
tail of the pancreas and spleen. B) The proposed system of ex-vivo laser ablation 
of human pancreatic cancer cells (red arrow, laser diode placed above the tumoral 
mass; blue arrow, the intra-arterial administration of hsA-MWcNT-FITc in the 
pancreatic magna artery; yellow arrow, the intra-arterial administration of custodiol 
solution in the splenopancreatic artery; black arrow, macroscopic aspect of tumor 
mass after photothermal treatment). 
Abbreviations:  FITC,  fluorescein  isothiocyanate;  HSA,  human  serum  albumin; 
MWcNT, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Tissue staining and imaging
For this purpose, multiple tissue samples were extracted 
from each region and from each surgical specimen, under 
ultrasound guidance. Thus, biopsy samples before, during, 
and after irradiation and treatment with HSA-MWCNTs were 
obtained from the tumor (central and peripheral area) and 
from the surrounding pancreatic tissue (5–10 mm outside 
the gross margins of the tumor), using TruCut needle (Dyna 
Medical, ON, Canada) biopsy.
Biopsies were immediately frozen in liquid nitrogen, 
stored at −70°C, and sectioned at 7 µm with a Leica RM 
2125 RT microtome (Wetzlar, Germany).
For the common histopathologic analysis, tissue specimens 
harvested from the tumor mass and the surrounding areas were 
immersed in 4% formaldehyde solution, after the photothermal 
treatment. The tissues were embedded in paraffin wax, serially 
sectioned, and stained with hematoxylin and eosin. Typical 
morphological characteristics were examined under light 
microscope. Thermal injury was assessed in sections using 
a semiquantitative scale, with a necrotic area percentage 
of 0 = normal; 1 = ,10%; 2 = 10%–50%; 3 = 50%–75%; 
4 = .75%. Light microscopy analysis was performed using 
an Olympus BX60 microscope (Hamburger, Germany).
electron microscopic observation
Biopsies specimens were extracted from several parts of 
the tumor and routinely prepared on 0.05 mm thin slides, 
monitoring the changes in the malignant tissue’s ultrastructural 
morphology, using a Jeol JEM 1010 transmission electron 
microscope (Jeol, Tokyo, Japan). The images were captured 
using a Mega VIEW III camera (Olympus, Soft Imaging 
System, Münster, Germany).
Temperature measurements
To characterize the baseline conditions and parameters 
for the proposed treatment method, continuous remote 
multithermometer reading was conducted in both the healthy 
and tumor tissue during the treatment, using a fast response 
Therma 20 handheld thermometer (Electronic Temperature 
Instruments, Worthing, UK), equipped with stainless steel, 
fast response, needle penetration probe. The thermistor 
probes were positioned inside the healthy or tumor tissue 
under ultrasound guidance.
statistical methods
The continuous data was tested for normality (Kolmogorov–
Smirnov test) before the hypothesis testing. The longitudinal 
data, representing repetitive measurements of the same 
parameter during the follow-up interval, were analyzed 
through the construction of kinetic curve along with the 
area under the curve (AUC) calculus. Consecutively, kinetic 
curves of two different groups were compared using Mann–
Whitney U test. Fisher’s exact test was used for qualitative 
data correlations. For all tests, a 0.05 threshold was selected 
for statistical significance. Statistical data analysis was 
performed using SPSS 17.0 software (Chicago, IL).
Results and discussion
Functionalization of MWcNTs with hsA
To obtain a targeted delivery of MWCNTs directly into 
the cancer cells, and to visualize and detect the localization 
of the nanotubes inside the cells, HSA-FITC was used 
and noncovalently labeled onto the oxidized surface of 
MWNTs.
Confocal microscopy has been proposed to identify 
fluorescein isothiocyanate (FITC) labeled CNTs in solution 
and to provide clues regarding the successfulness of 
noncovalent functionalization of MWCNTs with HSA-
FITC. As shown in Figure 3C, globular green MWCNTs, 
corresponding to large molecules of fluorescent albumin, 
were observed.
The oxidation of the nanotubes using a 3:1 (v/v) 
mixture of concentrated sulfuric and nitric acid gives them 
hydrophilicity and stability in aqueous systems due to the 
formation of COOH, OH groups at the end of and along 
the sidewalls of the tubes.28
Fourier transform infrared (FTIR) spectra from Figure 4A 
confirms successful oxidation. By comparing the FTIR 
spectra of pristine MWCNTs (black) with the oxidized-
MWCNTs (red), the characteristic bands of the oxygen-
containing groups appear at 3422 cm−1, corresponding to 
the OH stretching vibration,29 a week band at 1721 cm−1, 
corresponding to the carbonyl and carboxyl CO stretching 
vibration, at 1582 and 1380 cm−1, corresponding to the O-H 
deformation vibration, and at 1117 cm−1, corresponding to the 
CO stretching vibration. The band at 620 cm−1 corresponds 
to the CO out-of-plane deformation.30
Further, we have noncovalently conjugated HSA-FITC 
on the surface of oxidized MWCNTs. Firstly, we have 
covalently labeled HSA with FITC at an increased pH (above 
pH = 9), as schematically shown in Figure 3A. FITC has 
covalently attached to the protein through the alpha-amino 
group. Secondly, HSA-FITC complex has been adsorbed 
onto the nanotubes, presumably through electrostatic International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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interactions between the functional groups of MWCNTs 
and the protein-positive domains (Figure 3B). Taking into 
consideration the fact that not all the surface of the nanotubes 
is oxidized, hydrophobic interactions can also occur.
UV-Vis spectroscopy is a simple but efficacious method 
which confirms the formation of the oxidized MWCNT-
HSA-FITC complex. The nanotube solutions give an adsorb-
tion band at 295.7 nm, which corresponds to the +/−plasmon 
transition of MWCNTs.31
The yellowish HSA-FITC solution has the characteristic 
adsorbtion band at 489 nm and a second adsorbtion at 
292 nm, which suggests the existence of aromatic amino 
acids of HSA. Comparing the above mentioned spectra, the 
formation of the MWCNT-HSA-FITC complex becomes 
obvious due to the appearance of oxidized-MWCNT band 
and HSA-FITC band at 475.6 nm, which is shifted and has 
low intensity (Figure 4C).
The conjugation of HSA-FITC onto the nanotube surface 
is also confirmed by FTIR spectroscopy as seen in Figure 4B. 
No similarity can be observed when comparing the spectra of 
HSA-FITC with that of the nanotube-conjugated HSA-FITC. 
All the corresponding peaks had shifted their position, and 
some of them even disappeared. In the higher region, the 
stretching vibration band of the NH groups at 3409 cm−1 
Sodium buffer A
B
CD
HSA HSA-FITC
HSA-FITC
HSA-FITC
Oxidized MWCNTs-HSA-FITC Oxidized MWCNTs
Cox = Oxigen-containing surface groups
FITC
2h, stirring
at dark
1h Sonication
Cox Cox
XCO−
XCO−
2 µm
Figure 3 A) Illustration of chemical reactions used for the covalent labeling of hsA-FITc. B) schematic showing oxidized MWcNT-hsA-FITc formation. C) A typical 
fluorescent image of HSA-MWCNTs (100 mg/L): globular fluorescent carbon nanotubes corresponding to attached large molecule of fluorescent albumin are observed.   
D) 140 nm × 120 nm AFM topographic image of hsA (black arrows) conjugated to MWcNTs (white arrows). The red arrow indicates the presence of an unconjugated 
hsA molecule. The scale bar represents 20 nm. 
Abbreviations: AFM, atomic force microscopy; FITC, fluorescein isothiocyanate; HSA, human serum albumin; MWCNT, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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changed their shape in a broad band that included two peaks: 
one at 3389 cm−1 (NH groups stretching   vibration) and the 
second at 3303 cm−1, which is the pyridine aromatic CH 
stretching vibration band. The aliphatic CH stretching 
vibration band at 2929 and 2873 cm−1 moved to 2922 
and 2865 cm−1, showing that these groups are involved in 
electrostatic bonds. Amide I and II are also shifted to low 
frequency: amide I from 1656 to 1649 cm−1, amide II from 
1544 to 1532 cm−1. The CH3 asymmetric and symmetric 
deformation changed their band from 1459 to 1447 cm−1, and 
from 1416 to 1389 cm−1. The region in between dramatically 
changed their intensity. This is due to the spontaneous 
adsorbtion of the crystalline HSA-FITC complex onto the 
MWCNTs and the formation of a well organized oxidized 
MWCNT-HSA-FITC.
Furthermore, atomic force microscopy (AFM) analysis of 
the HSA-MWCNT solution was performed. A representative 
AFM evidence of the successful attachment of HSA 
molecules onto the surface of the nanotubes is shown in Fig-
ure 3D. AFM allowed the analysis at the nanometric scale of 
the two HSA molecules (black arrows in Figure 3D) attached 
to the end of the nanotubes (white arrows). A single HSA 
molecule (red arrow) has been also observed in the topo-
graphic image shown. The length of the CNTs was estimated 
as being lower than 200 nm. The lateral resolution of an AFM 
image is determined by the tip of the object that is imaged. In 
the presented image, the width of the nanotube appears to be 
greater than 2 nm, as we used an AFM tip having a ∼15 nm 
radius of curvature.
ex-vivo testing procedure
The main goal of this investigation was to develop and 
test a new method of treatment of human pancreatic 
adenocarcinoma. Preliminary literature data supports the 
involvement of albumin in tumor growth. In the present 
study, we tested a carrier-linked CNT system based on HSA 
for the selective delivery and laser mediated ex-vivo ablation 
of living human PC tissue (Figures 2A and 2B).
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The central hypothesis of the study was that albumin 
will carry the MWCNTs inside the tumor tissue after intra-
arterial perfusion. To test this hypothesis, we developed an 
experimental platform using viable resected specimens from 
patients who underwent curative treatment of PC.
Despite their attractiveness in nanomedicine, in-vitro 
test conditions cannot duplicate the host environment due 
to the variability of the testing media (eg, acidic   versus 
alkaline, differences in cation content), and exhibit   limiting 
effect of protein binding on cell surface receptors.32 
Moreover, the controlled conditions present in in-vitro 
biosystems are   significantly different from those in vivo, and 
properties of nanoparticles such as high adsorption   capacity, 
hydrophobicity, surface charge, optical and magnetic 
properties, or catalytic activity may be modified.33
On the other hand, obvious potential pitfalls of nanopho-
tothermolysis experiments on mice models are   represented by 
the morphology and size of the tumor, which are fundamentally 
different than that of human tumors. Thus, all the particularities 
of human tumors such as vessel anatomy and distribution, and 
volume and location, are not comparable to these models.
cytotoxicity induced by laser irradiation 
or internalization of hsA-MWcNTs
To avoid a potential bias, we investigated the possible 
necrotic effect of simple laser irradiation. For this purpose, 
using fine needle biopsy, we extracted tumor samples before 
and after irradiation, without HSA-MWCNTs. As shown in 
Figures 5A and 5B, no differences regarding size and shape, 
nuclear modifications or necrosis, were observed at the 
histopathological analysis of the specimens, before and after 
irradiation. For similar reasons, we analyzed tumor specimens 
after the simple internalization of HSA-MWCNTs. As shown 
in Figure 5C, no morphological changes were noticed in the 
extracted samples after administration.
In addition, terminal TUNEL assay was performed, 
suggesting that there was no difference regarding the   apoptotic 
rate among the examined tissues (data not shown).
Internalization of cNTs
The ability of FITC-labeled bioconjugate of HSA-MWCNTs 
to internalize inside the tumor cells after administration via 
vascular supply has been assessed by confocal fluorescence 
and electron microscopy imaging.
The area with the highest concentration of HSA-MW-
CNTs was observed in the central part of the tumor, where 
most of the malignant cells were stained with fluorescent dye 
(Figure 6C). The malignant tissue extracted from the periph-
ery of the tumor also presented intracytoplasmic MWCNT-
HSA-FITC. However, a lower density of fluorescent 
nanotubes was noted compared with the central region of the 
tumor (Figure 6B). No fluorescence was observed outside the 
tumor in the surrounding healthy parenchyma (Figure 6A). 
Thus, we have provided imagistic evidence that HSA can act 
as delivery carrier of MWCNTs, and because we were unable 
to identify any fluorescence in the healthy pancreatic tissue, 
we reasoned that the HSA-MWCNT bioconjugates exhibit 
100% affinity for ductal adenocarcinoma cells. These data 
ABC
Figure 5 Preserved tumoral architecture after laser treatment or hsA-MWcNT 
administration. A) Before irradiation/administration: tumoral structures infiltrating 
between  normal  pancreatic  acini  (black  arrows)  h&e  stain,  obx100,  (scale  bar 
represents 400 µm). B) After irradiation: normal pancreatic acini with chromatic 
polarity and infiltrating tumoral structures (black arrows) H&E stain, obx200 (scale 
bar represents 400 µm). C) After hsA-MWcNT administration: normal tumoral 
duct structures lined by a single layer of polymorphic columnar cells surrounded 
by the desmoplastic stromal reaction (black arrows) h&e stain, obx200 (scale bar 
represents 200 µm). results are representative of three experiments. 
Abbreviations: h&e, hematoxylin and eosin stain; hsA, human serum albumin; 
MWcNT, multiwalled carbon nanotubes.
A
20 µm2 0 µm
B
C
20 µm
D
Figure 6 confocal imaging of the tissue samples after intra-arterial FITc-hsA-
MWcNT administration (A–C). electron microscopy of tumor tissue after hAs-
MWcNT-mediated  photothermal  treatment.  A)  surrounding  pancreatic  tissue.   
B) Peripheral area of the tumor. C) central region of the tumor (red, nuclei stained 
by DrAQ5™ coloration; green, intracellular FITc-hsA-MWcNTs). results are 
representative of three experiments. D) electron microscopy demonstrates necrotic 
features with disintegrated nuclei in the tumor tissue after treatment (blue arrows). 
Intracellular clusters of MWcNTs could also be demonstrated (red arrows). scale 
bar: 2 µm. 
Abbreviations:  FITC,  fluorescein  isothiocyanate;  HSA,  human  serum  albumin; 
MWcNT, multiwalled carbon nanotubes.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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support on the one hand the involvement of the vascular 
architecture of the malignant lesion tributary to pancreatic 
magna artery and on the other hand the specificity of HSA 
for cell receptors in the selective internalization of HSA-
MWCNTs.
Moreover, electron microscopy of the tissue after 
treatment showed necrotic features with disintegrated 
nuclei, and intracellular clusters of MWCNTs, suggesting 
the   efficacy of nanophotothermal ablation.
The mechanism of selective 
internalization of hsA-MWcNTs  
inside the malignant pancreatic cells
To shed light on the molecular mechanisms involved in the 
specific internalization of HSA-MWCNTs in the pancreatic 
malignant cells, we investigated the possibility that a 60 kDa 
glycoprotein, gp60, which is known to function in albumin 
transcytosis in malignant cells,34 was involved in the selective 
internalization of albumin bound to CNTs. To accomplish 
this, we let the cells treated with 5 mg/L HSA-MWCNTs for 
1 hour incorporate cy3–anti-gp60 antibody for 30 minutes 
at 37°C. Therefore, we obtained fluorescent images proving 
the internalized cy3 fluorescence (Figure 1B).
Alternatively, we showed that PANC-1 cells internalized 
albumin-bound MWCNTs (fluorescently labeled with 
FITC) that were distributed into the punctate structure 
inside the cells (Figure 1A). DAPI, which is known to 
form fluorescent complexes with natural double-stranded 
DNA, was used for nuclei staining. In Figure 1C, a nearly 
complete co-localization of the FITC fluorescence (green 
image) and cy3 fluorescence (red image) was emphasized by 
the yellow color in the merged image. This finding   suggests 
that albumin-bound MWCNTs were incorporated into the 
plasmalemmal vesicles containing gp60 as a membrane 
protein, further validating HSA-MWCNT specificity for 
gp60 receptors. Therefore, based on this data, we showed 
that HSA-MWCNTs can act as specific and sensitive site-
targeted nanosystems against gp60 receptors located on the 
PC cell membranes.
Very recent clinical trials suggest that specific target-
ing of GP60 (albondin) receptor with Abraxane (Celgene, 
Summit, USA), a cytostatic drug called paclitaxel bound to 
human albumin may prolong the survival in advanced cases 
of PC.35 For the first time, the results of this study demon-
strate that HSA-MWCNTs exploit the albondin receptor, 
in a similar manner, penetrating the blood-stroma barrier 
with consequent delivery of active nanomaterial inside the 
malignant cells (Figure 7).
Temperature measurements
Laser irradiation of cancer cells labeled with HSA-MWCNTs 
may be used in two modes: pulse and continuous. The pulse 
mode produces localized (few micrometers) damage of 
individual cancer cells by laser-induced micro- and nano-
bubbles around overheated nanoparticles, without harmful 
effects on the surrounding healthy cells. It particularly 
favors in-vivo destruction of single circulating tumor cells 
only by using nanosecond laser pulses. The second mode is 
more time consuming (a few minutes of exposure) and has 
the thermal denaturation and coagulation effects as main 
mechanisms of cell damage. It is more appropriate to treat 
primary tumors with sizes of several millimeters.36 Based on 
these data, we used continuous laser to irradiate the tumor 
after the internalization of HSA-MWCNTs.
There was no difference in tissue temperature among 
the three areas measured at baseline (Figure 8): 1) the 
central region of the tumoral mass; 2) the peripheral region, 
2–5 mm away from the edge of the hypoechogenic tumor 
mass; and 3) the healthy pancreatic tissue surrounding the 
tumor.   Statistical analysis of the maximal tissue temperature 
among the three areas revealed that the heating curves of the 
area under the curve (AUC) corresponding to the central 
and peripheral regions of the tumor were significantly 
higher (P . 0.05) than the heating curves obtained from 
the temperature measurements in the pancreatic tissue. This 
indicates that the heating process following the irradiation 
and HSA-MWCNT treatment mainly occurred in the tumor 
mass. As shown in Figure 8B the maximal tissue temperatures 
(4.2°C in the surrounding healthy tissue; 25.6°C at the 
periphery of the tumor; 29.3°C in the central region of the 
tumor) were approximately achieved after 20 minutes of 
irradiation combined with the simultaneous administration of 
HSA-MWCNTs. The findings in Figure 8 demonstrate that 
after 20 minutes of laser irradiation combined with   ex-vivo 
intra-arterial administration, the temperature elevations in the 
tumor tissue are high enough to produce extensive necrosis 
of the tumor compared with the harmless effects on the 
healthy parenchyma. In a separate experiment, 200 mg/L 
of highly purified solution of unconjugated MWCNTs were 
Administration Binding Internalization NIR necrosis
Figure 7 schematic illustration of hsA-MWcNT-mediated ablation of pancreatic 
cancer. 
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simultaneously administered in combination with external 
laser irradiation. Temperature measurements displayed a 
maximal increase (delta t = 16.6°C) in the superficial pan-
creatic tissue above the tumor (closest to the laser diode). 
Moreover, the temperature magnitude at the periphery of the 
tumor closest to the laser beam was of only 9.7°C, while in 
the middle and distant margins of tumor the increase was 
of only 6.2°C and 4.5°C respectively. These changes were 
further confirmed by the histopathological analysis displaying 
extensive necrotic areas in the healthy tissue located in the 
vicinity of the laser diode, as suggested by the histological 
scores (Figure 9E). Thus, we obtained evidence that ex-vivo 
intra-arterial administration of highly purified unconjugated 
MWCNTs is tributary to the architecture of the capillary bed 
inside the pancreatic parenchyma, further demonstrating 
the nonselective distribution of the nanomaterial inside the 
pancreatic tissue (both healthy and malignant).
Remote thermistors may be independently placed inside 
the tissue, and can measure intraprocedural tissue tem-
peratures. In the present study, the CNT mediated thermal 
activation of tissues was similar to that reported by other 
papers.37
hsP response to MWcNT-mediated 
photothermal therapy
To confirm the results mentioned above, we have used an 
independent measure of heat generation: induction of HSPs, 
which are induced by elevated temperatures and serve as 
endogenous cellular markers of thermal stress. As seen in 
Figure 8A, minimal expression exists for all HSPs in the 
surrounding tissue, after treatment. Maximal HSP27 and 
HSP90 expression were induced in the tumor tissue.
Assessment of tumor necrosis after laser 
treatment and internalization  
of hsA-MWcNTs
In the present study, we have used MWCNTs as heat inducing 
agents under laser radiation, in order to obtain a selective 
necrosis of the malignant lesion. This method is based on 
the presence and clustering of MWCNTs inside the targeted 
cells. Their highly optical absorption capacity is   responsible 
for inducing thermal effects under NIR irradiation, where 
the biological systems have low absorption and high 
transparency.38 The optoelectronic transitions in the graphitic 
structures of the MWCNT clusters generate thermal energy39 
that rapidly diffuses into the subcellular compartments where 
the nanobioconjugates are present.
In this ex-vivo experiment, the pancreas was preserved 
in crystalloid perfusion combined with cold storage. 
  Simultaneously, HSA molecules bound to MWCNTs were 
directly perfused in the greater pancreatic artery under 
ultrasound guidance. The next step was to irradiate the 
hypoechogenic tumor mass.
After combined irradiation and intra-arterial perfusion of 
HSA-MWCNTs, all sections were evaluated in detail for any 
cell shape changes (cell shrinkage, extraordinary cytoplasmic 
eosinophilia, clear cell change, cytoplasmic vacuolization), 
nuclear changes (nucleomegaly, multinucleation, hyper-
chromasia, symplastic changes), and coagulative necrosis. 
The histopathological examination clearly revealed foci 
0
0 200 400 600 800 1000
Time (sec)
1200 1400 1600 1800 2000
1
2
3
4
Healthy tissue (∆Tmax;°C)
Tumor (periphery) (∆Tmax;°C)
Tumor (central) (∆Tmax;°C)
5
0
5
10
15
20
25
0
5
10
15
20
25
30
AB HSP 27
P
a
n
c
r
e
a
s
T
u
m
o
r
HSP 90
Figure 8 Thermal response to hsA-MWcNT-mediated photothermal therapy. A) The top row of images depicts basal level of expression of hsP27 (green) and hsP90 
(red) in healthy, surrounding tissue. The lower row of images depict hsP expression in tumor sections. B) 3 Y-plot chart of time-temperature curves obtained from the 
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with sizes ranging from 500 µm to a few millimeters, with 
common signs of thermal cell necrosis, present in all the 
examined malignant slides in the entire tumor mass, mostly 
in its central area.
A representative histopathological image of such necrosis 
is shown in Figure 9C: the malignant cells are shrunken, 
with loss of contact, eosinophilic cytoplasm and nuclear 
damage (pyknotic and fragmentized nuclei). The apoptotic 
bodies were present (Figure 9B). At the same time as the 
destruction of the tumor cells, thermal injury was observed 
in the stromal reactive tissue. Both the extracellular matrix 
and the cellular components of the desmoplastic reaction 
were affected. As shown in Figure 9B, the connective tissue 
surrounding the tumor cells was disrupted (oedematous), 
with fragmented, acidophilic collagen fibers. Some foci 
revealed hydropic degeneration, with cell ballooning due 
to intracitoplasmatic vacuolization of the tumor cells 
(Figure 9B). Due to the impaired staining characteristics, no 
clear demarcation between the viable and necrotic cells was 
observed. Figure 9D shows few areas of preserved tumoral 
architecture, with tumoral and glandular structures lined by 
mucus-secreting columnar cells alternating with thermally 
damaged, shrunken cells. No morphologic changes were 
noticed during the histopathological analysis of the samples 
extracted from the pancreatic tissue surrounding the tumor. 
Figure 9A illustrates the histological characteristics of this 
tissue after photothermal treatment. Normal pancreatic 
structure with secretory units or acini consisting of a single 
layer of pyramidal cells, surrounded by connective tissue, 
Langerhans islets and pancreatic ducts could be observed. 
These findings were additionally confirmed by electron 
microscopy analysis.
Histological scoring indicated that pancreatic damage was 
more pronounced in malign tissue after treatment. As seen 
in Figure 9E, overall histological scores showed a marked 
increase in malign cell death (where necrotic areas were 
more than 50%, on all the examined slides), whereas necrotic 
cells were observed only sporadically in tissue obtained from 
healthy, surrounding parenchyma. For control solution, tissue 
disruption and cell death was observed predominantly in the 
surrounding tissue. These data, together with the observation 
of massive HSA-MWCNT accumulation in the tumor tissue, 
suggest that the combination of HSA-MWCNTs and laser 
irradiation produces selective necrosis of human PC.
To investigate the selectivity and efficacy of the proposed 
treatment, terminal TUNEL assay was performed in order to 
stain the necrotic nuclei of apoptotic cells on the examined 
slides. As seen in Figures 10A–10C, based on this method, 
we obtained strong imaging evidence that more than 95% 
of the tumor cells were apoptotic after irradiation. On the 
other hand, the apoptotic rate of the surrounding healthy cells 
was less than 2% (Figures 10D–10F) on all the examined 
slides (P , 0.0001). These observations strongly suggest 
the specific nature of our treatment and confirmed its effi-
cacy in inducing selective apoptosis in human pancreatic 
adenocarcinoma.
The hallmark of cell lysis is represented by DNA 
degradation, which in the early stages is selective to the 
internucleosomal DNA linker regions. The DNA cleavage 
may yield double-stranded and single-stranded DNA breaks 
(nicks). Both types of breaks can be detected by labeling 
the free 3′OH termini with modified nucleotides such as 
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Figure  9  histopathological  aspects  of  the  tissue  after  hsA-MWcNT  intra-
arterial administration and laser irradiation. A) surrounding pancreatic tissue after 
irradiation. Normal acinar cells with staining polarity and pancreatic duct lined by 
cuboidal epithelium. No structural changes were observed. h&e stain, obx400 (scale 
bar represents 100 µm). B) Tumoral duct after irradiation. Distortion of the tumor 
structures, with loss of cell contact, piknotic and fragmented nuclei (black arrows); 
edematous  extracellular  matrix,  disrupted,  intense  acidophilic  fibers  of  collagen 
(blue arrows); apoptotic bodies (red arrow). h&e stain, obx40 (scale bar represents 
100 µm). C) Periphery of the tumor. Foci of thermal lysis consisting of destructed 
tumoral ducts and desmoplastic reaction structures. h&e stain, obx4 (scale bar 
represents 1000 µm). D) central area of the tumor. An extensive region of thermal 
lysis  of  cancer  cells  can  be  observed.  h&e  stain,  obx10  (scale  bar  represents 
400 µm). E) histological scores of necrosis in healthy and malign tissue. Thermal 
injury was assessed in sections using a semiquantitative scale in which the percentage 
of necrotic areas was assigned a score: 0 = normal; 1 = ,10%; 2 = 10%–50%; 
3 = 50%–75%; 4 = .75%. results are representative of three experiments. 
Abbreviations: h&e, hematoxylin and eosin stain; hsA, human serum albumin; 
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fluorescein-dUTP in an enzymatic reaction. The terminal 
deoxynucleotidyl transferase (TdT) catalyzes the template-
independent polymerization of deoxyribonucleotides to the 
3′-end of single- and double-stranded DNA. This method is 
recognized for its high sensitivity and specificity for apoptotic 
cell detection in tissue sections.40 This selective destruction 
of the tumor tissue has additionally confirmed the efficacy 
of the selective internalization of MWCNTs, with HSA 
cargo, inside the ductal pancreatic adenocarcinoma after 
intra-arterial perfusion.
According to the information provided by the remote 
temperature measurements, in the present study, the 
HSA-MWCNT-mediated heating was tumor-specific, and 
consequently, the risk of damaging collateral structures 
was insignificant. Therefore, a clinical development of such 
treatment would have great benefit.
If we dissect the molecular detail of the HSA-MWCNT-
mediated laser ablation mechanism, we obtain a selective 
necrosis of each malignant cell at a micrometric scale, with 
consequent global tumor involution. This is of decisive 
importance since all the current thermal ablation techniques 
in surgery rely on the use of invasive electrodes that 
  generate high local temperature (90°C), with nonselective 
carbonization of the tissue. Therefore, methods such as 
radiofrequency or ultrasound ablation are not used in pan-
creatic surgery (they have limited applications in liver and 
kidney tumor treatment).41 Due to the burning effects on the 
tissue, complications of these techniques in surgical practice, 
such as the extensive destruction of normal tissue with organ 
failure, residual abscesses, vascular injuries and peritoneal 
hemorrhage, neoplastic seeding, and intestinal perforation, 
are quite common.42
The spread of PC cells in the systemic circulation, 
with consequent seeding in other organs, a process called 
metastasis, is the cause of most PC-related deaths. Thus, the 
development of selective targeted therapies able to destroy 
these circulating cells could open a new era in the treatment 
of PC. Therefore, there is a dire need for innovations of such 
molecular “Trojan horses”, able to produce safe single-cell 
necrosis, with minimal side effects.
In this experiment, all the existent situations met in 
surgical practice were replicated. We reasoned that, from a 
surgical point of view, the ultrasound identification of the 
tumor and its vascular supply, the intra-arterial administra-
tion of the functionalized MWCNTs, as well as the external 
laser irradiation, could all be safely achieved in patients by 
means of minimally invasive surgery, with major benefits 
for the patient (eg, laparoscopic approach or percutaneous 
approach under ultrasound/CT guidance).
Conclusion
We showed for the first time that HSA-MWCNTs are 
selectively internalized in human pancreatic adenocarcinoma 
cells through the binding of albumin carrier to the gp60 
receptor. Moreover, to our best knowledge, this is the first 
demonstration of the therapeutic potential of intra-arterially 
delivered nanobioconjugates in living human tumors. This is 
of decisive importance, especially with regard to the initiation 
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Figure 10 Postirradiation effects after intra-arterial administration of hsA-MWcNTs. TUNeL TMr apoptosis assay (red), DAPI nuclear staining (blue), and overlay.   
A–C) Pancreatic adenocarcinoma. D–G) Normal pancreatic tissue. scale bar: 100 µm. results are representative of three experiments. 
Abbreviations: DAPI, 4′,6-diamidino-2-phenylindole; hsA, human serum albumin; MWcNT, multiwalled carbon nanotubes; TUNeL, transferase dUTP nick end labeling.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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of this therapeutic method in clinical trials. The proposed 
ex-vivo platform could be further used for the development 
and testing of new nanobioconjugates with specificity for PC. 
Thus, starting from this model, other ex-vivo platforms (eg, 
human hepatocellular carcinoma, kidney tumors) can be built, 
with the purpose of testing new active nanobiomolecules 
against human cancers.
The above results assign human albumin as having a 
good potential for use as a selective delivery carrier for the 
development of CNT-based targeting agents in the treat-
ment of PC. This original therapeutic strategy (intra-arterial 
administration of nanobiosystems in living human organs) 
presented in this paper will likely increase the knowledge 
of CNT-mediated photothermal therapy in cancer and will 
open new doors in oncological research. Nevertheless, further 
research is required for the careful assessment of unexpected 
toxicities and biological interactions of HSA-MWCNTs 
inside the living organism.
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